| Insider | Title | Company | Date | Price | Return | Shares | Value |
|---|---|---|---|---|---|---|---|
| Reardon Tighe | Acting Chief Financial Officer | Janux Therapeutics, Inc. (JANX) | 2023-11-13 | $5.87 | 644.6% | 849,854 | $4,988,643 |
| Reardon Tighe | Acting Chief Financial Officer | Janux Therapeutics, Inc. (JANX) | 2021-06-15 | $17.00 | 157.1% | 629,411 | $10,699,987 |
| Return | Profit / (loss) | Cost | |||||
| Total | 312.1% | $48,970,042 | $15,688,630 |